Nephros Announces Presentations at Five Upcoming Investor Conferences
September 03 2019 - 7:30AM
via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a
commercial-stage company that develops and sells high performance
water purification products to the medical device and commercial
markets, today announced presentations at five upcoming investor
conferences.
Daron Evans, President and Chief Executive
Officer, and Andy Astor, Chief Operating and Financial Officer,
will provide overviews of Nephros’ business during the conferences
and will be available for one-on-one meetings with registered
participants. Company information, including the most recent
corporate presentation, is available on the Nephros website:
https://www.nephros.com/investor-relations/
LD Micro San Francisco SummitDate:
Tuesday, September 3Time: 8:40am Pacific
TimeLocation: JW Marriott, San FranciscoSpeaker:
Daron EvansFor more information: https://www.ldmicro.com
RHK Capital 2019 Disruptive Growth ConferenceDate:
Wednesday, September 4Time: 2:40pm Eastern
TimeLocation: Reed Smith, New York, NYSpeaker: Andy
AstorFor more information and webcast:
http://disruptnyc.com
Fall Investor SummitDate: Monday, September
16Time: 9:00am Eastern TimeLocation: The Essex House,
New York, NYSpeaker: Andy AstorFor more information:
https://microcapconf.com
MicroCap Leadership SummitDate:
Friday, September 27, 2019Time: All dayLocation:
Westin Chicago Northwest Hotel, Itasca, IllinoisSpeaker:
Andy Astor
For more information:
https://microcapclub.com/summit/
LD Micro New York City SummitDate: Monday, October
7, 2019Time: 9:00am Eastern TimeLocation: Lowenstein
Sandler, 1251 6th Ave., New York, NYSpeaker: Andy
AstorFor more information:
https://www.ldmicro.com/events
About Nephros, Inc.
Nephros is a commercial stage company that
develops and sells high performance water purification products to
the medical device and commercial markets. Nephros ultrafilters are
used in hospitals and medical clinics for added protection in
retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from
water, providing barriers that assist in improving infection
control in showers, sinks, and ice machines. Additionally, Nephros
ultrafilters are used by dialysis centers for assisting in the
added removal of endotoxins and other biological contaminants from
the water and bicarbonate concentrate supplied to hemodialysis
machines and patients.
Nephros filters, including AETHER™ brand
filters, improve the taste and odor of water and reduce biofilm,
bacteria, and scale build-up in downstream equipment. Nephros and
AETHER™ products are used in the health care, food service,
hospitality, and convenience store markets.
For more information about Nephros, please visit
our website at www.nephros.com.
Investor Relations Contact:
Kirin Smith, President
PCG Advisory, Inc.
(646) 863-6519
ksmith@pcgadvisory.com
Nephros (NASDAQ:NEPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nephros (NASDAQ:NEPH)
Historical Stock Chart
From Apr 2023 to Apr 2024